Merrimack to Participate in Pancreatic Cancer Panel at the 2013 BIO CEO & Investor Conference

[at noodls] – CAMBRIDGE, Mass., Feb. 7, 2013 (GLOBE NEWSWIRE) — Merrimack Pharmaceuticals, Inc. (Nasdaq:MACK) today announced that Peter Laivins, Vice President of Late Stage Clinical Development and Project Leader … more

View todays social media effects on MACK

View the latest stocks trending across Twitter. Click to view dashboard

See who Merrimack is hiring next, click here to view